Endoskopie 2009; 18(3): 118-123

Radiofrequency ablation in therapy of Barret’s esophagus - our first experience

MUDr. Přemysl Falt, MUDr. Ondřej Urban Ph.D, MUDr. Petr Fojtík, MUDr. Martin Kliment
Centrum péče o zažívací trakt, Vítkovická nemocnice a. s., Ostrava

Barrett´s esophagus is associated with an increased risk of developing neoplastic alterations. Early Barrett´s neoplasia with low risk of

lymphatic dissemination can be treated by means of endoscopy in order to avoid surgery. Endoscopic mucosal resection is a method of

choice in the case of a visible neoplastic lesion. Moreover, it serves as an optimal local staging procedure. The rest of Barrett´s epithelium

can be removed by endoscopic ablation techniques and radiofrequency ablation seems to be the most promising one. Authors

report their first experience in this field.

Keywords: Barrett´s esophagus, dysplasia, adenocarcinoma, endoscopic mucosal resection, ablation techniques, radiofrequency ablation.

Published: October 16, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Falt P, Urban O, Fojtík P, Kliment M. Radiofrequency ablation in therapy of Barret’s esophagus - our first experience. Endoskopie. 2009;18(3):118-123.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pouw RE, Sharma VK, Bergman JJ, Fleischer DE. Radiofrequency ablation for total Barrett´s eradication: a description of the endoscopic technique, its clinical results and future prospects. Endoscopy 2008; 40: 1033-1040. Go to original source... Go to PubMed...
    2. Závada F. Radiofrekvenční ablace Barrettova jícnu. Endoskopie 2007; 16(1): 12-14.
    3. Martínek J, Zavoral M. Barrettův jícen - jak sledovat a jak léčit. Postgraduální medicína 2009; 11(6): 674-682.
    4. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E. Prevalence of Barrett´s esophagus in the general population: an endoscopic study. Gastroenterology 2005; 129(6): 1825-1831. Go to original source... Go to PubMed...
    5. Westhoff B, et al. The frequency of Barrett´s esophagus in high-risk patients with chronic GERD. Gastrointest Endosc 2005; 61: 226-231. Go to original source... Go to PubMed...
    6. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104(2): 510-513. Go to original source... Go to PubMed...
    7. Bytzer, et al. Adenocarcinoma of the esophagus and Barrett´s esophagus: a population-based study. Am J Gastroenterol 1999; 94(1): 86-91. Go to original source... Go to PubMed...
    8. Conio M, et al. Secular trends in the epidemiology and outcome of Barrett´s esophagus in Olmstead County, Minnesota. Gut 2001; 48(3): 304-309. Go to original source... Go to PubMed...
    9. Cameron AJ, et al. Adenocarcinoma of the esophagogastric junction and Barrett´s esophagus. Curr Surgery 2003; 60(4): 367-370.
    10. Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett´s esophagus. Clin Gastroenterol Hepatol 2006; 4: 566-572. Go to original source... Go to PubMed...
    11. Martinek J, Benes M, Brandtl P, Hucl T, Vasicek M, Voska l, Lanská V, Nosek V, Spicak J. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett´s esophagus: a prospective cohort study. Endoscopy 2008; 40: 711-716. Go to original source... Go to PubMed...
    12. Skacel M, Petras RE, Gramlich TL, et al. The diagnosis of low-grade dysplasia in Barrett´s esophagus and its implications for disease progression. Am J Gastroenterol 2000; 95: 3383-3387. Go to original source... Go to PubMed...
    13. Lim CH, et al. Low-grade dysplasia in Barrett´s esophagus has a high risk of progression. Endoscopy 2007; 39: 581-587. Go to original source... Go to PubMed...
    14. Spechler SJ. Dysplasia in Barrett´s esophagus: limitations of current management strategies. Am J Gastroenterol 2005; 100: 927-935. Go to original source... Go to PubMed...
    15. Stein HJ, et al. Limited resection for early adenocarcinoma in Barrett´s esophagus. Ann Surg 2000; 232(6): 733-742. Go to original source... Go to PubMed...
    16. Van Sandick JW, et al. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 2000; 88(11): 2429-2437. Go to original source...
    17. Bollschweiler E, Baldus SE, Schröder W, Prenzel K, Gutschow C, Schneider PM, Hölscher AH. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 2006; 38(2): 149-156. Go to original source... Go to PubMed...
    18. Westerterp M, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005; 446: 497-504. Go to original source... Go to PubMed...
    19. Nigro JJ, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implication fot therapy. J Thorac Cardiovasc Surg 1999; 117(1): 26-27. Go to original source... Go to PubMed...
    20. Heitmiller RF, Redmond M, Hamilton SR. Barrett´s esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996; 224(1): 66-71. Go to original source... Go to PubMed...
    21. van Lanschot JJ, Hulscher JB, Buskens CJ, et al. Hospital volume and hospital mortality for esophagectomy. Cancer 2001; 91: 1574-1578. Go to original source...
    22. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-1669. Go to original source... Go to PubMed...
    23. Williams VA, Watson TJ, Herbella FA, et al. Esophagectomy for high grade dysplasia is safe, curative and results in good alimentary outcome. J Gastrointest Surg 2007; 11: 1589-1597. Go to original source... Go to PubMed...
    24. Ell C, May A, Pech O, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett´s cancer). Gastrointest Endosc 2007; 65: 3-10. Go to original source... Go to PubMed...
    25. Peters FP, et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett´s esophagus. Gastrointest Endosc 2008; 67(4): 604-609. Go to original source... Go to PubMed...
    26. Maish MS, DeMeester SR. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann Thorac Surg 2004; 78(5): 1777-1782. Go to original source... Go to PubMed...
    27. May A. Stop confusing us with EUS prior to endoscopic resection. Endoscopy 2008; 40: 71-72. Go to original source... Go to PubMed...
    28. Chemaly M, Scalone O, Durivage G, Napoleon B, Pujol B, Lefort C, Hevrieux V, Scoazec JY, Souquet JC, Ponchon T. Miniprobe EUS in the pretherapeutic assessment of early esophageal neoplasia. Endoscopy 2008; 40(1): 71-72. Go to original source... Go to PubMed...
    29. May A, Guenter E, Roth E, et al. Accuracy of staging in oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004; 53: 634-540. Go to original source... Go to PubMed...
    30. Mucosal ablation devices - technology status evaluation report. Gastrointest Endosc 2008; 68(6): 1031-1042.
    31. Seewald S, Ang TL, Gotoda T, Soehendra N. Total endoscopic resection of Barrett esophagus. Endoscopy 2008; 40: 1016-1020. Go to original source... Go to PubMed...
    32. Wang KK, Lutzke L, Borkenhagen L, Westra W, Song MWK, Prasad G, Buttar NS. Photodynamic therapy for Barrett´s esophagus: does light still have a role? Endoscopy 2008; 40: 1021-1025. Go to original source... Go to PubMed...
    33. Dumot JA, Greenwald BD. Argon plasma coagulation, bipolar cautery, and cryotherapy: ABC´s of ablative techniques. Endoscopy 2008; 40: 1026-1032. Go to original source... Go to PubMed...
    34. Dunkin BJ, Martin J, Bejarano PA, et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Endosc 2006; 20(1): 125-130. Go to original source... Go to PubMed...
    35. Smith CD, Bejarano PA, Melvin WS, et al. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation systém. Surg Endosc 2007; 21(4): 560-569. Go to original source... Go to PubMed...
    36. Sharma V, Wang K, Overholt B, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett´s esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007; 65: 185-195. Go to original source... Go to PubMed...
    37. Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett´s esophagus: a multicenter study with 2,5 year follow-up. Gastrointest Endosc 2008; 68: 867-876. Go to original source... Go to PubMed...
    38. Sharma VK, Kim HJ, Das A, Dean P, DePetris G, Fleischer DE. A prospective pilot trial of ablation of Barrett´s esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy 2008; 40: 380-387. Go to original source... Go to PubMed...
    39. Gondrie JJ, Pouw RE, Sondermeijer CM, Peters FP, Curvers WL, Rosmolen WD, Krishnadath KK, Ten Kate F, Fockens P, Bergman JJ. Stepwise circumferential and focal ablation of Barrett´s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008; 40(5): 359-369. Go to original source... Go to PubMed...
    40. Gondrie JJ, Pouw RE, Sondermeijer CM, Peters FP, Curvers WL, Rosmolen WD, Ten Kate F, Fockens P, Bergman JJ. Effective treatment of early Barrett´s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008; 40(5): 370-379. Go to original source... Go to PubMed...
    41. Shaheen NJ, et al. A randomized, multicenter, sham-controlled trial od radiofrequency ablation for subjects with Barrett´s esophagus containing high-grade dysplasia. Gastroenterology 2008; 134: A37. Go to original source...
    42. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RF, Wang KK, et al. Radiofrequency ablation in Barrett´s esophagus with dysplasia. N Engl J Med. 2009; 360(22): 2353-2535. Go to original source... Go to PubMed...
    43. Gondrie JJ, Rygiel AM, Sondermeijer C, et al. Balloonbased circumferential ablatin followed by focal ablation of Barrett´s esophagus containing high-grade dysplasia effectively removes all genetic alterations. Gastroenterology 2007; Supplementum S1: 132: A64.
    44. Finkelstein SD, Lyday WD. The molecular pathology of radiofrequency mucosal ablation of Barrett´s esophagus. Gastroenterology 2008; 134(4): A436. Go to original source...
    45. Beaumont H, Gondrie JJ, McMahon BP, Pouw RE, Gregersen H, Bergman JJ, Boeckstaens GE. Stepwise radiofrequency ablation of Barrett´s esophagus preserves esophageal inner diameter, compliance and motility. Endoscopy 2009; 41: 2-8. Go to original source... Go to PubMed...

    Return to the content


    Endoscopy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.